Display options
Cite
Withrington PG, Ansari N, Croxton R, et al. The actions of endothelins-1 and -3 on the vascular and capsular smooth muscle of the isolated blood perfused spleen of the dog. Br J Pharmacol. 1992;105(2):490-4doi: 10.1111/j.1476-5381.1992.tb14281.x.
Withrington, P. G., Ansari, N., Croxton, R., de Nucci, G., & Vane, J. R. (1992). The actions of endothelins-1 and -3 on the vascular and capsular smooth muscle of the isolated blood perfused spleen of the dog. British journal of pharmacology, 105(2), 490-4. https://doi.org/10.1111/j.1476-5381.1992.tb14281.x
Withrington, P G, et al. "The actions of endothelins-1 and -3 on the vascular and capsular smooth muscle of the isolated blood perfused spleen of the dog." British journal of pharmacology vol. 105,2 (1992): 490-4. doi: https://doi.org/10.1111/j.1476-5381.1992.tb14281.x
Withrington PG, Ansari N, Croxton R, de Nucci G, Vane JR. The actions of endothelins-1 and -3 on the vascular and capsular smooth muscle of the isolated blood perfused spleen of the dog. Br J Pharmacol. 1992 Feb;105(2):490-4. doi: 10.1111/j.1476-5381.1992.tb14281.x. PMID: 1559137; PMCID: PMC1908655.
Copy Download .nbib Format: NLM
Share it on
Full text links
Wiley Free PMC Article

Br J Pharmacol. 1992 Feb;105(2):490-4. doi: 10.1111/j.1476-5381.1992.tb14281.x.

The actions of endothelins-1 and -3 on the vascular and capsular smooth muscle of the isolated blood perfused spleen of the dog.

British journal of pharmacology

P G Withrington, N Ansari, R Croxton, G de Nucci, J R Vane

Affiliations

  1. Department of Pharmacology, Faculty of Basic Medical Sciences, Queen Mary and Westfield College, London.

PMID: 1559137 PMCID: PMC1908655 DOI: 10.1111/j.1476-5381.1992.tb14281.x
Free PMC Article

Abstract

1. Endothelin-1 (ET-1), endothelin-3 (ET-3) and noradrenaline (NA) were administered as intra-arterial bolus injections into the isolated, blood-perfused spleen of the dog to assess agonist properties and relative molar potencies on the vascular and capsular smooth muscle. 2. An initial small vasodilatation was observed occasionally at low doses (1.0-10 pmol) of ET-1. 3. ET-1, ET-3 and NA all caused graded increases in splenic arterial vascular resistance. The molar ED50 for the splenic vasoconstrictor response to ET-1 was significantly less (P less than 0.001) than that to ET-3; both peptides were significantly more potent as vasoconstrictor agents than NA. The maximum increase in splenic arterial vascular resistance was not significantly different for either ET-1, ET-3 or NA. 4. The time course of the splenic vasoconstrictor response to ET-1 was significantly (P less than 0.01) longer than that to equieffective doses of ET-3 or NA. 5. The splenic vasoconstrictor responses to ET-1 and ET-3 were accompanied by reductions in spleen volume. The rank order of molar potency in causing splenic capsular contraction was ET-1 greater than ET-3 greater than NA. The maximum reduction in splenic volume was significantly greater for NA than for either ET-1 or ET-3. The two peptides (ET-1, ET-3) were equiefficacious in contracting splenic capsular smooth muscle. 6. The high molar potency of ET-1 as a splenic arterial vasoconstrictor, over 1,700 times more potent than NA, suggests that it may play an important local role in the control of splenic haemodynamics.

Similar articles

References

  1. Nature. 1990 Dec 20-27;348(6303):732-5 - PubMed
  2. J Physiol. 1973 Jan;228(1):13-25 - PubMed
  3. J Cardiovasc Pharmacol. 1989;13 Suppl 5:S50-6; discussion S74 - PubMed
  4. J Cardiovasc Pharmacol. 1989;13 Suppl 5:S93-7; discussion S102 - PubMed
  5. Br J Pharmacol. 1989 Aug;97(4):1297-307 - PubMed
  6. Br J Pharmacol. 1989 Mar;96(3):675-87 - PubMed
  7. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2863-7 - PubMed
  8. Eur J Pharmacol. 1989 Jun 8;165(1):161-4 - PubMed
  9. Br J Pharmacol. 1989 Apr;96(4):823-8 - PubMed
  10. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6964-7 - PubMed
  11. Br J Pharmacol. 1987 Apr;90(4):785-90 - PubMed
  12. Arch Int Pharmacodyn Ther. 1969 Jul;180(1):143-54 - PubMed
  13. Br J Pharmacol. 1990 Jan;99(1):107-12 - PubMed
  14. J Cardiovasc Pharmacol. 1989;13 Suppl 5:S209-10 - PubMed
  15. J Cardiovasc Pharmacol. 1989;13 Suppl 5:S85-8; discussion S102 - PubMed
  16. Br J Pharmacol. 1989 Oct;98(2):646-52 - PubMed
  17. Cell Tissue Res. 1985;239(1):9-18 - PubMed
  18. Am J Physiol. 1989 Apr;256(4 Pt 2):R858-66 - PubMed
  19. Br J Pharmacol. 1988 Oct;95(2):664-70 - PubMed
  20. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9797-800 - PubMed
  21. Peptides. 1987 Mar-Apr;8(2):399-410 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources